单位:[1]First Central Clinical College, Tianjin Medical University, Tianjin 300192, China.[2]Key Laboratory of Organ Transplantation of Tianjin, Tianjin 300071, China.[3]Oriental Organ Transplant Center, Tianjin First Central Hospital, Tianjin 300192, China.[4]Tianjin Nankai Hospital, Tianjin 300100, China.[5]Affiliated Hospital of Logistics University of Chinese People’s Armed Police Forces, Tianjin 300162, China.[6]Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.首都医科大学附属北京友谊医院[7]Department of Immunology and Inflammation, Tianjin Medical University, Tianjin 300070, China
Increasing evidence has linked autophagy to a detrimental role in hepatic ischemia-reperfusion (IR) injury (IRI). Here we focus on the role of interferon regulatory factor-1 (IRF-1) in regulating autophagy to aggravate hepatic IRI. We found that IRF-1 was up-regulated during hepatic IRI and was associated with an activation of the autophagic signaling. This increased IRF-1 expression, which was allied with high autophagic activity, amplified liver damage to IR, an effect which was abrogated by IRF-1 depletion. Moreover, IRF-1 contributed to P38 induced autophagic and apoptotic cell death, that can play a key role in liver dysfunction. The levels of P62 mRNA and protein were increased when P38 was activated and decreased when P38 was inhibited by SB203580. We conclude that IRF-1 functioned as a trigger to activate autophagy via P38 activation and that P62 was required for this P38-mediated autophagy. IRF-1 appears to exert a pivotal role in hepatic IRI, by predisposing hepatocytes to activate an autophagic pathway. Such an effect promotes autophagic cell death through the P38/P62 pathway. The identification of this novel pathway, that links expression levels of IRF-1 with autophagy, may provide new insights for the generation of novel protective therapies directed against hepatic IRI.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270554]; National Key Specialty Construction of Clinical Projects [201354409]; Tianjin Basic Applied Research Project [05YFJMJC 14800]
第一作者单位:[1]First Central Clinical College, Tianjin Medical University, Tianjin 300192, China.[2]Key Laboratory of Organ Transplantation of Tianjin, Tianjin 300071, China.
共同第一作者:
通讯作者:
通讯机构:[2]Key Laboratory of Organ Transplantation of Tianjin, Tianjin 300071, China.[3]Oriental Organ Transplant Center, Tianjin First Central Hospital, Tianjin 300192, China.
推荐引用方式(GB/T 7714):
Yu Yao,Li Shipeng,Wang Zhen,et al.Interferon regulatory factor-1 activates autophagy to aggravate hepatic ischemia-reperfusion injury via the P38/P62 pathway in mice[J].SCIENTIFIC REPORTS.2017,7:doi:10.1038/srep43684.
APA:
Yu, Yao,Li, Shipeng,Wang, Zhen,He, Jindan,Ding, Yijie...&Zhu, Zhijun.(2017).Interferon regulatory factor-1 activates autophagy to aggravate hepatic ischemia-reperfusion injury via the P38/P62 pathway in mice.SCIENTIFIC REPORTS,7,
MLA:
Yu, Yao,et al."Interferon regulatory factor-1 activates autophagy to aggravate hepatic ischemia-reperfusion injury via the P38/P62 pathway in mice".SCIENTIFIC REPORTS 7.(2017)